These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21303380)

  • 1. Molecular pathogenesis of hepatocellular carcinoma.
    Cornellà H; Alsinet C; Villanueva A
    Alcohol Clin Exp Res; 2011 May; 35(5):821-5. PubMed ID: 21303380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics and signaling pathways in hepatocellular carcinoma.
    Villanueva A; Newell P; Chiang DY; Friedman SL; Llovet JM
    Semin Liver Dis; 2007 Feb; 27(1):55-76. PubMed ID: 17295177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
    Kudo M
    Dig Dis; 2011; 29(3):273-7. PubMed ID: 21829017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
    Yamazaki K; Masugi Y; Sakamoto M
    Dig Dis; 2011; 29(3):284-8. PubMed ID: 21829019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways and gene expression profiles in hepatocellular carcinoma.
    Facciorusso A; Nacchiero MC; Rosania R; Laonigro G; Giorgio F; Del Prete V; Panella C; Ierardi E
    Minerva Gastroenterol Dietol; 2012 Mar; 58(1):35-48. PubMed ID: 22419003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of hepatocellular carcinoma and molecular therapies.
    Mínguez B; Tovar V; Chiang D; Villanueva A; Llovet JM
    Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of hepatocellular carcinoma.
    McKillop IH; Moran DM; Jin X; Koniaris LG
    J Surg Res; 2006 Nov; 136(1):125-35. PubMed ID: 17023002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative drive and liver carcinogenesis: too much of a good thing?
    Teoh NC
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1817-25. PubMed ID: 20002941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the natural history of hepatocellular carcinoma.
    Trevisani F; Cantarini MC; Wands JR; Bernardi M
    Carcinogenesis; 2008 Jul; 29(7):1299-305. PubMed ID: 18515282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma.
    Dahmani R; Just PA; Perret C
    Clin Res Hepatol Gastroenterol; 2011 Nov; 35(11):709-13. PubMed ID: 21778132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of hepatobiliary carcinogenesis.
    Nault JC; Zucman-Rossi J
    Semin Liver Dis; 2011 May; 31(2):173-87. PubMed ID: 21538283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signatures and prognosis of hepatocellular carcinoma.
    Hoshida Y
    Minerva Gastroenterol Dietol; 2011 Sep; 57(3):311-22. PubMed ID: 21769080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW; Poon RT
    Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
    Marquardt JU; Galle PR; Teufel A
    J Hepatol; 2012 Jan; 56(1):267-75. PubMed ID: 21782758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis viruses and hepatocarcinogenesis].
    Kiss A; Lotz G; Kaposi NP; Schaff Z
    Orv Hetil; 2002 Jan; 143(2):83-6. PubMed ID: 11868453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatocellular carcinoma: molecular biology aspects].
    Blum HE
    Zentralbl Chir; 1994; 119(11):759-63. PubMed ID: 7846955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of signaling pathways in the development and treatment of hepatocellular carcinoma.
    Whittaker S; Marais R; Zhu AX
    Oncogene; 2010 Sep; 29(36):4989-5005. PubMed ID: 20639898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.